News

Our latest press releases, media appearances and topical commentary.





News
07 March 2025
Medicines Discovery Catapult Wins Bionow Business Support Award

MDC is recognised for its support of the Life Sciences sector





The Intracellular Drug Discovery Centre releases Regulatory Roadmap for RNA Therapeutics and Vaccines to simplify commercialisation pathway.
News
18 February 2025
Commercialisation Pathway Simplified with New Regulatory Roadmap for RNA Therapeutics and Vaccines

Intracellular Drug Delivery Centre has developed the go-to guide with input from MHRA


A picture of Wellcome and MDC's logo Psychiatry Consortium explaining the programme helps enable early and robust target validation research for mental health drug discovery.
News
12 February 2025
New Funding Available to Mental Health Drug Discovery Innovators

Wellcome, in collaboration with MDC’s Psychiatry Consortium, launches funding call to support mental health drug innovators


Scientific Experts Join MDC Board of Directors to further bolster the catapult's mission of reshaping drug discovery for patient benefit.
News
30 January 2025
Scientific Experts Join Medicines Discovery Catapult’s Board of Directors

New Board members bring diverse additional life science expertise to MDC


News
17 January 2025
MDC Publishes First Year of ESG Progress

Reshaping drug discovery, responsibly


News
16 January 2025
Turning Nuclear Waste into Breakthrough Cancer Treatments

Funding awarded by UKRI to explore sustainable manufacturing of new targeted radiotherapy treatments that could improve patient outcomes


News
13 January 2025
Medicines Discovery Catapult Strengthens Senior Leadership Team with Two Executive Appointments

Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director


News
28 November 2024
Patient and Ministers Unveil NPIP’s First Total-Body PET Scanner as London Site Becomes Operational

Science and Health Ministers visited the site, accompanied by the first patient to be scanned using the cutting-edge technology, which will help unlock medical breakthroughs


News
21 November 2024
CF AMR Syndicate Wins Most Impactful Industry Collaboration of the Year Award

Recognition of the CF AMR Syndicate’s impact this World AMR Awareness Week (18-24 November 2024)


News
26 September 2024
Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation

PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us



We are ISO 45001 certified 

The world’s first international standard for occupational health and safety. The accreditation has been certified by Interface NRM, a UKAS and ASI–accredited certification body.











Medicines Discovery Catapult